Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 14 February, 2019

J.P. Morgan Sec PLC

Stabilisation Notice

RNS Number : 0107Q
J.P. Morgan Securities PLC.
14 February 2019
 

14th February 2019

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Acquirente Unico S.p.A.

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement 13 February 2019, J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

Issuer:

Acquirente Unico S.p.A.

Guarantor (if any):

 

Aggregate nominal amount:

EUR 500mn

Description:

EUR 7yr FXD

Lux MTF list /  English Law / 100k+1k /

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

 

Offer price:

99.506%

 

 

 

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
STAEAPALFSANEEF

a d v e r t i s e m e n t